These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28360191)

  • 41. IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.
    Wang Z; Xu L; Chang Y; Zhou L; Fu H; Zhang W; Yang Y; Xu J
    Tumour Biol; 2016 Aug; 37(8):11127-34. PubMed ID: 26926076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
    An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
    Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.
    Choi JW; Lee JH; Park HS; Kim YS
    J Clin Pathol; 2011 Oct; 64(10):893-7. PubMed ID: 21725041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.
    Gong X; Siprashvili Z; Eminaga O; Shen Z; Sato Y; Kume H; Homma Y; Ogawa S; Khavari PA; Pollack JR; Brooks JD
    Oncotarget; 2017 Mar; 8(12):18657-18669. PubMed ID: 28423633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
    Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
    Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma.
    Zhu C; Wei J; Tian X; Li Y; Li X
    Int J Clin Exp Pathol; 2015; 8(10):12668-77. PubMed ID: 26722456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Demethylation of miR-10b plays a suppressive role in ccRCC cells.
    He C; Zhao X; Jiang H; Zhong Z; Xu R
    Int J Clin Exp Pathol; 2015; 8(9):10595-604. PubMed ID: 26617769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
    Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
    Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
    Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
    BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
    Slaby O; Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R
    Genes Chromosomes Cancer; 2012 Jul; 51(7):707-16. PubMed ID: 22492545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.
    Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X
    Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of c-Met in prognosis and clinicopathology of renal cell carcinoma: Results from a single-centre study and systematic review.
    Chen S; Zhu Y; Cui J; Wang Y; Xia Y; Song J; Cheng S; Zhou C; Zhang D; Zhang B; Shi B
    Urol Oncol; 2017 Aug; 35(8):532.e15-532.e23. PubMed ID: 28427859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma.
    Vergho D; Kneitz S; Rosenwald A; Scherer C; Spahn M; Burger M; Riedmiller H; Kneitz B
    BMC Cancer; 2014 Jan; 14():25. PubMed ID: 24428907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.
    May M; Brookman-Amissah S; Roigas J; Gilfrich CP; Pflanz S; Hoschke B; Gunia S
    Urol Oncol; 2010; 28(3):274-9. PubMed ID: 18805709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical and biological significance of MICA in clear cell renal cell carcinoma patients.
    Zhang X; Yan L; Jiao W; Ren J; Xing N; Zhang Y; Zang Y; Wang J; Xu Z
    Tumour Biol; 2016 Feb; 37(2):2153-9. PubMed ID: 26349747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
    Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
    Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
    Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
    Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
    Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma.
    Zhao Z; Lu J; Qu H; Wang Z; Liu Q; Yang X; Liu S; Ge J; Xu Y; Li N; Yuan Y
    Hum Pathol; 2018 Oct; 80():87-93. PubMed ID: 29935195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.